헬스케어 분야 블록체인 : 시장 점유율 분석, 업계 동향 및 통계, 성장 예측(2026-2031년)

According to Mordor Intelligence, the blockchain market size In Healthcare market is expected to grow from USD 5.5 billion in 2025 to USD 8.27 billion in 2026 and is forecast to reach USD 63.58 billion by 2031 at 50.38% CAGR over 2026-2031.

This report is Segmented by Application ( Clinical Data Exchange, Billing and Claims Adjudication and More), End-User ( Providers (Hospitals, Clinics), Pharma / Med-Tech Manufacturers and More), Blockchain Type ( Private / Permissioned, Consortium, and Public ) and Geogrpahy.

Global Blockchain In Healthcare Market Trends and Insights

Rising Cyber-Breach Costs Push CIO Budgets Toward Blockchain Security

Healthcare breaches compromised more than 500 million records since 2020, and average incident costs reached USD 10.93 million in 2024. The February 2024 Change Healthcare attack, which halted USD 22 million in daily claims and triggered a USD 22 million bitcoin ransom, underscored centralized system vulnerabilities. Distributed ledgers fit zero-trust architectures by offering tamper-evident audit trails, data provenance, and multi-party verification that satisfy the Department of Health and Human Services' voluntary Cybersecurity Performance Goals. As insurers tighten underwriting criteria and regulators highlight blockchain for critical data integrity, CIOs now budget blockchain as core cybersecurity spend rather than innovation-hub outlay. This shift accelerates full-scale network rollouts across provider systems and payer clearinghouses

US & EU DSCSA / FMD Serialization Deadlines Mandate End-to-End Drug Traceability

The Drug Supply Chain Security Act's enhanced requirements, extended but firm through 2026, compress implementation windows for serialized transactions. An FDA pilot with IBM, KPMG, Merck, and Walmart delivered 100% traceability compared with 73% under legacy tools, proving blockchain efficiency. Europe's Falsified Medicines Directive exerts parallel pressure as serialized National Drug Codes demand unbroken auditability. Trading partners lacking electronic connections risk supply-chain exclusion, pushing pharmaceutical distributors to adopt permissioned ledgers that mesh GS1 EPCIS standards with smart contracts. Regulatory clarity on electronic pedigrees, therefore, moves blockchain from an opportunity choice to an operational prerequisite.

High Migration Cost from Legacy HIS Limits Near-Term Rollouts

Large hospital systems spend USD 15-25 million on core HIS migrations and another USD 5-8 million for blockchain-ready middleware and staff upskilling. Legacy EHR stacks deployed more than a decade ago lack modern API layers, requiring custom connectors or full system overhaul-a budget strain for community hospitals. Maintaining HIPAA safeguards during transition raises legal and insurance liabilities that boards are hesitant to absorb. The Change Healthcare breach clarified the risks of inaction, but its USD 2.3 billion recovery bill also highlighted the capital burden of technology replacement. Consequently, many providers schedule blockchain adoption in phased pilots tied to broader EHR renewal cycles, moderating near-term uptake

Other drivers and restraints analyzed in the detailed report include:

1. Payer Pressure to Cut Duplicate Claims Fuels Smart-Contract Adjudication
2. Growing EHR Interoperability Projects Accelerate Demand
3. Fragmented Global Health-Data Regulations Complicate Cross-Border Chains

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Clinical Data Exchange secured 45.40% of the blockchain in healthcare market share in 2025, underpinned by TEFCA mandates that make verifiable information exchange a core provider obligation. The segment benefits from mature HL7-FHIR integrations and secure share-and-query workflows that minimize record duplication. Billing & Claims Adjudication follows as insurers implement smart contracts to cut USD 68 billion in duplicate payments. Conversely, Clinical Trials & Consent Management is the growth pacesetter with a 71.04% CAGR to 2031 as sponsors require immutable consent logs and decentralized recruitment. Pharmaceutical firms report 40% shorter enrollment windows after shifting to blockchain-verified permissions. Supply-Chain & Provenance solutions linked to DSCSA compliance round out the stack, ensuring serialized drug visibility down to unit level. The blockchain in healthcare market size for applications serving patient-centric consent networks is projected to expand at 71.04% annually through 2031, reshaping trial economics and patient engagement.

The convergence of AI with dynamic smart consent allows patients to grant time-boxed or condition-based data rights that expire automatically, embedding privacy by design. Automated royalty frameworks pay participants when their data drives trial insights, while zero-knowledge proofs preserve anonymity. Hospitals thereby transition from passive record custodians to active data brokers, and venture funding increasingly flows into platforms that operationalize patient ownership concepts at scale. Regulatory endorsement by the FDA for distributed trial evidence further propels adoption, turning consent management into a cornerstone for decentralized research networks.

Complete Report Scope:

• By Application
  • Clinical Data Exchange
  • Billing and Claims Adjudication
  • Supply-Chain and Provenance
  • Clinical Trials and Consent Mgmt
• By End-User
  • Providers (Hospitals, Clinics)
  • Payers and PBMs
  • Pharma / Med-tech Manufacturers
  • Patients and Health-Data Brokers
• By Blockchain Type
  • Private / Permissioned
  • Consortium
  • Public
• By Geography
  • North America
    • United States
    • Canada
  • South America
    • Brazil
    • Argentina
  • Europe
    • Germany
    • United Kingdom
    • France
    • Russia
  • Asia-pacific
    • China
    • Japan
    • India
  • Middle East and Africa
    • GCC
    • South Africa

Geography Analysis

North America accounted for 40.95% of blockchain in healthcare market share in 2025, sustained by DSCSA serialization, TEFCA interoperability demands, and heightened breach-containment costs. The USD 22 million daily disruption from the 2024 Change Healthcare attack underscored the stakes, driving healthcare systems to allocate 6-10% of total IT budgets to cybersecurity-centric ledger deployments. Large hospital chains such as the Mayo Clinic and payer groups, including Anthem, now combine HL7-FHIR gateways with blockchain notarization for claims and medical records, while the Department of Veterans Affairs runs pilots for longitudinal patient wallets. Federal guidance from HHS that cites blockchain in critical-data-integrity recommendations cements its role across provider and payer stacks.

Asia-Pacific is the growth nucleus with a 61.18% CAGR through 2031. China's national health data platform mandates blockchain-anchored data provenance, though localization laws require in-country node residency. Japan's 2024 Medical Law amendments explicitly promote digital-health tech, spurring hospital consortia to pilot blockchain for telemedicine and prescription verification. India's Ayushman Bharat Digital Mission combines patient-controlled health IDs with sandboxed blockchain pilots, while the forthcoming Digital Personal Data Protection Act shapes privacy overlays. ASEAN nations integrate blockchain into medical-tourism corridors, ensuring secure transfer of diagnostic images and prescriptions for cross-border patients seeking treatment in Singapore and Thailand.

Europe maintains steady momentum as GDPR necessitates immutable but revocable audit trails, prompting region-wide interest in zero-knowledge proofs and off-chain storage hybrids. The European Blockchain Service Infrastructure publishes healthcare-specific guidelines that help member states converge on common consent receipts and digital signing standards. Germany's Hospital Future Act funds blockchain proofs of record provenance, and the Nordics extend e-prescription platforms onto consortium chains. In the Middle East & Africa, Gulf Cooperation Council smart-city programs embed blockchain to manage citizen health wallets and pharmaceutical logistics, while South Africa pilots decentralized records at Frere Provincial Hospital. These deployments illustrate how resource-constrained markets leapfrog legacy IT by adopting ledger systems that bundle security, identity, and traceability.

1. IBM Corporation
2. Microsoft Corporation
3. Guardtime
4. Hashed Health
5. Patientory Inc.
6. Factom Inc.
7. Oracle Healthcare
8. Hyperledger Foundation
9. Change Healthcare (Optum)
10. BurstIQ
11. Chronicled Inc.
12. Medicalchain
13. Rymedi
14. Nebula Genomics
15. PokitDok (Change Health)
16. Embleema
17. Blockpharma
18. Solve.Care
19. BurstIQ
20. GEM Health

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 Study Assumptions and Market Definition
• 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET LANDSCAPE

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Rising cyber-breach costs push CIO budgets toward blockchain security
  • 4.2.2 US and EU DSCSA / FMD serialisation deadlines mandate end-to-end drug traceability
  • 4.2.3 Payer pressure to cut duplicate claims fuels smart-contract-based adjudication
  • 4.2.4 Growing EHR interoperability projects (e.g., TEFCA in the US) accelerate demand
  • 4.2.5 Tokenised health-data marketplaces create new revenue lines for hospital chains
  • 4.2.6 AI-ready federated learning pilots require blockchain-anchored model proofs
• 4.3 Market Restraints
  • 4.3.1 High migration cost from legacy HIS limits near-term rollouts
  • 4.3.2 Fragmented global health-data regulations complicate cross-border chains
  • 4.3.3 Public-cloud carbon-footprint targets delay PoW-based implementations
• 4.4 Value/Supply-Chain Analysis
• 4.5 Regulatory Landscape
• 4.6 Technological Outlook
• 4.7 Porter's Five Forces
  • 4.7.1 Threat of New Entrants
  • 4.7.2 Bargaining Power of Buyers
  • 4.7.3 Bargaining Power of Suppliers
  • 4.7.4 Threat of Substitutes
  • 4.7.5 Intensity of Competitive Rivalry

5 MARKET SIZE AND GROWTH FORECASTS (VALUE)

• 5.1 By Application
  • 5.1.1 Clinical Data Exchange
  • 5.1.2 Billing and Claims Adjudication
  • 5.1.3 Supply-Chain and Provenance
  • 5.1.4 Clinical Trials and Consent Mgmt
• 5.2 By End-User
  • 5.2.1 Providers (Hospitals, Clinics)
  • 5.2.2 Payers and PBMs
  • 5.2.3 Pharma / Med-tech Manufacturers
  • 5.2.4 Patients and Health-Data Brokers
• 5.3 By Blockchain Type
  • 5.3.1 Private / Permissioned
  • 5.3.2 Consortium
  • 5.3.3 Public
• 5.4 By Geography
  • 5.4.1 North America
    • 5.4.1.1 United States
    • 5.4.1.2 Canada
  • 5.4.2 South America
    • 5.4.2.1 Brazil
    • 5.4.2.2 Argentina
  • 5.4.3 Europe
    • 5.4.3.1 Germany
    • 5.4.3.2 United Kingdom
    • 5.4.3.3 France
    • 5.4.3.4 Russia
  • 5.4.4 Asia-pacific
    • 5.4.4.1 China
    • 5.4.4.2 Japan
    • 5.4.4.3 India
  • 5.4.5 Middle East and Africa
    • 5.4.5.1 GCC
    • 5.4.5.2 South Africa

6 COMPETITIVE LANDSCAPE

• 6.1 Market Concentration
• 6.2 Strategic Moves
• 6.3 Market Share Analysis
• 6.4 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products and Services, and Recent Developments)
  • 6.4.1 IBM Corporation
  • 6.4.2 Microsoft Corporation
  • 6.4.3 Guardtime
  • 6.4.4 Hashed Health
  • 6.4.5 Patientory Inc.
  • 6.4.6 Factom Inc.
  • 6.4.7 Oracle Healthcare
  • 6.4.8 Hyperledger Foundation
  • 6.4.9 Change Healthcare (Optum)
  • 6.4.10 BurstIQ
  • 6.4.11 Chronicled Inc.
  • 6.4.12 Medicalchain
  • 6.4.13 Rymedi
  • 6.4.14 Nebula Genomics
  • 6.4.15 PokitDok (Change Health)
  • 6.4.16 Embleema
  • 6.4.17 Blockpharma
  • 6.4.18 Solve.Care
  • 6.4.19 BurstIQ
  • 6.4.20 GEM Health

7 MARKET OPPORTUNITIES AND FUTURE OUTLOOK

• 7.1 White-Space and Unmet-Need Assessment